Daxxify

Active Ingredient(s): Daxibotulinumtoxina-lanm
FDA Approved: * September 7, 2022
Pharm Company: * REVANCE THERAPEUTICS, INC.
Category: Skin Care
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Daxxify 100 U/1.2ml Intramuscular Injection, Powder, Lyophilized, for Solution
NDC: 72960-112
Labeler:
Revance Therapeutics, Inc.